Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product 2015-10-28
  2. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation 2015-01-06
  3. Clinical trials of intravenous immunoglobulin for Alzheimer's disease 2014-04-24

Studies

5 studies carry this tag.

Date range

2012 to 2015

Top journals

  • Biochemistry 1
  • International immunopharmacology 1
  • Journal of clinical immunology 1
  • Journal of neuroimmunology 1
  • Journal of neuroinflammation 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuroimmunology 2015-10-28 Drug development

    The latest therapeutic approaches to Alzheimer disease are using intravenous immunoglobulin (IVIG) products.

  2. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Biochemistry 2015-01-06 Drug development

    Tau pathology, including neurofibrillary tangles, develops in Alzheimer's disease (AD).

  3. Clinical trials of intravenous immunoglobulin for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of clinical immunology 2014-04-24 Treatments

    The human polyclonal IgG antibody preparation known as Intravenous Immunoglobulin (IVIG) has been under study as a potential treatment for Alzheimer's disease (AD) since 2002.

  4. Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. International immunopharmacology 2013-05-10 Drug development

    Intravenous immunoglobulin (IVIG) products are prepared from plasma immunoglobulins from healthy donors.

  5. Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of neuroinflammation 2012-05-29 Treatments

    Our data indicate limited ability of hIVIG to impact amyloid burden but shows changes in microglia, pro-inflammatory gene expression, and neurogenic effects.

All topic tags with their study counts